Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Gastroenterology

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/GAST.2002.34453PMID 12105866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonalcoholic fatty liver disease: An agenda for clinical research

  2002cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

  2001cited by this paper
• The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans

  2001cited by this paper
• Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis

  2001cited by this paper
• Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

  2001cited by this paper
• The continuing epidemics of obesity and diabetes in the United States.

  2001cited by this paper
• Role of diabetes mellitus in the etiology of hepatocellular carcinoma.

  2000cited by this paper
• Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?

  2000cited by this paper
• Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study

  2000cited by this paper
• Body composition and hepatic steatosis as precursors for fibrotic liver disease

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• The disease burden associated with overweight and obesity.

  1999cited by this paper
• Association of nonalcoholic fatty liver disease with insulin resistance.

  1999cited by this paper
• Hepatocellular carcinoma

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

  1998cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Nonalcoholic steatohepatitis: an expanded clinical entity.

  1994cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper
• Nonalcoholic steatohepatitis: a study of 49 patients.

  1989cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper

• Recent research trends and updates on nonalcoholic fatty liver disease

  2018cites this paper
• Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease

  2012cites this paper
• Hypoxia, oxidative stress, and benzo[a]pyrene induced carcionogenesis

  2012cites this paper
• Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

  2012cites this paper
• Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity.

  2012cites this paper
• Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice

  2012cites this paper
• Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease

  2010cites this paper
• Hepatocellular carcinoma in patients with cryptogenic cirrhosis.

  2009cites this paper
• [Nonalcoholic steatohepatitis: pathogenesis and treatment].

  2008cites this paper
• Safety of Statin Therapy in Patients with Preexisting Liver Disease

  2008cites this paper
• Major liver resection for hepatocellular carcinoma in the morbidly obese: A proposed strategy to improve outcome

  2008influential citation
• Dipeptidyl peptidase IV (DDP IV) in NASH patients.

  2007cites this paper
• Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

  2007cites this paper
• Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison.

  2007cites this paper
• Epidemiology and natural history of NAFLD and NASH.

  2007cites this paper
• Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

  2006cites this paper
• Non-Alcoholic steatohepatitis and primary hepatic carcinoma

  2006cites this paper
• Epidemiología e historia natural de la hepatopatía grasa no alcohólica primaria

  2006cites this paper
• Epidemiology of primary and secondary liver cancers.

  2006cites this paper
• [Epidemiology and natural history of primary nonalcoholic fatty liver disease].

  2006cites this paper
• Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

  2006cites this paper
• Esteatosis hepática y resistencia a la insulina: ¿qué ocurre primero?

  2006cites this paper
• Liver disease in patients with diabetes mellitus.

  2006cites this paper
• Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.

  2006cites this paper
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

  2005cites this paper
• Pathogenesis and Management of Non-alcoholic Steatohepatitis

  2005cites this paper
• Steatosi associata al virus dell'epatite C e steatosi metabolica. Patologie diverse o sovrapposte?

  2005cites this paper
• Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma

  2005cites this paper
• Nonalcoholic steatohepatitis and the metabolic syndrome.

  2005cites this paper
• Nonalcoholic Fatty Liver (NAFL): Overview

  2005cites this paper
• Carcinome hépatocellulaire en l’absence de cirrhose au cours d’une stéato-hépatite non alcoolique

  2004cites this paper
• Nonalcoholic Steatohepatitis

  2004cites this paper
• Obesity and diabetes as a risk factor for hepatocellular carcinoma

  2004cites this paper
• Pharmacologic management of nonalcoholic fatty liver disease.

  2004cites this paper
• [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].

  2004cites this paper
• A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients

  2004cites this paper
• Obesity and hepatocellular carcinoma.

  2004cites this paper
• The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease.

  2004cites this paper
• [Improving insulin resistance: certain progress in the management of patients with non-alcoholic steatohepatitis...but the story continues].

  2004cites this paper
• Améliorer l'insulinorésistance : un progrès certain dans la prise en charge des malades atteints de stéato-hépatite non alcoolique... mais l'histoire continue

  2004cites this paper
• [Non-alcoholic steatohepatitis: therapeutic management].

  2003cites this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cites this paper
• Orlistat in the Treatment of NASH: A Case Series

  2003cites this paper
• Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.

  2003cites this paper